41 related articles for article (PubMed ID: 35426830)
1. Comparative analysis of bevacizumab and LITT for treating radiation necrosis in previously radiated CNS neoplasms: a systematic review and meta-analysis.
Gecici NN; Gurses ME; Kaye B; Jimenez NLF; Berke C; Gökalp E; Lu VM; Ivan ME; Komotar RJ; Shah AH
J Neurooncol; 2024 May; 168(1):1-11. PubMed ID: 38619777
[TBL] [Abstract][Full Text] [Related]
2. Management of symptomatic radiation necrosis after stereotactic radiosurgery and clinical factors for treatment response.
Sayan M; Mustafayev TZ; Balmuk A; Mamidanna S; Kefelioglu ESS; Gungor G; Chundury A; Ohri N; Karaarslan E; Ozyar E; Atalar B
Radiat Oncol J; 2020 Sep; 38(3):176-180. PubMed ID: 33012145
[TBL] [Abstract][Full Text] [Related]
3. PRIDE complex-like skin rash associated with bevacizumab.
Singh B; Rajput A; Tripathi M; Mahajan R
BMJ Case Rep; 2022 Jul; 15(7):. PubMed ID: 35868802
[TBL] [Abstract][Full Text] [Related]
4. A phase 2 study of thalidomide for the treatment of radiation-induced blood-brain barrier injury.
Cheng J; Jiang J; He B; Lin WJ; Li Y; Duan J; Li H; Huang X; Cai J; Xie J; Zhang Z; Yang Y; Xu Y; Hu X; Wu M; Zhuo X; Liu Q; Shi Z; Yu P; Rong X; Ye X; Saw PE; Wu LJ; Simone CB; Chua MLK; Mai HQ; Tang Y
Sci Transl Med; 2023 Feb; 15(684):eabm6543. PubMed ID: 36812346
[TBL] [Abstract][Full Text] [Related]
5. Ependyma in Neurodegenerative Diseases, Radiation-Induced Brain Injury and as a Therapeutic Target for Neurotrophic Factors.
Ma XY; Yang TT; Liu L; Peng XC; Qian F; Tang FR
Biomolecules; 2023 Apr; 13(5):. PubMed ID: 37238624
[TBL] [Abstract][Full Text] [Related]
6. A New Generation of IMiDs as Treatments for Neuroinflammatory and Neurodegenerative Disorders.
Kopp KO; Greer ME; Glotfelty EJ; Hsueh SC; Tweedie D; Kim DS; Reale M; Vargesson N; Greig NH
Biomolecules; 2023 Apr; 13(5):. PubMed ID: 37238617
[TBL] [Abstract][Full Text] [Related]
7. Microglia as Therapeutic Target for Radiation-Induced Brain Injury.
Liu Q; Huang Y; Duan M; Yang Q; Ren B; Tang F
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955439
[TBL] [Abstract][Full Text] [Related]
8. Intraarterial administration of melphalan for treatment of intracranial human glioma xenografts in athymic rats.
Kurpad SN; Friedman HS; Archer GE; McLendon RE; Petros WM; Fuchs HE; Guaspari A; Bigner DD
Cancer Res; 1995 Sep; 55(17):3803-9. PubMed ID: 7641197
[TBL] [Abstract][Full Text] [Related]
9. Five-Fraction Radiosurgery Using a Biologically Equivalent Dose of a Single Fraction of 24 Gy for a 3-cm Parasagittal Para-Central Sulcus Brain Metastasis From Adenocarcinoma of the Cecum.
Ohtakara K; Kondo T; Obata Y; Fujii K; Suzuki K
Cureus; 2023 Nov; 15(11):e48799. PubMed ID: 38098911
[TBL] [Abstract][Full Text] [Related]
10. Bevacizumab reduces peritumoral brain edema in lung cancer brain metastases after radiotherapy.
Hua YC; Gao DZ; Wang KY; Ding XS; Xu WR; Li YB; Shi WW; Sun SB; Li XY
Thorac Cancer; 2023 Nov; 14(31):3133-3139. PubMed ID: 37718465
[TBL] [Abstract][Full Text] [Related]
11. Radionecrosis mimicking pseudo‑progression in a patient with lung cancer and brain metastasis following the combination of anti‑PD‑1 therapy and stereotactic radiosurgery: A case report.
Ji X; Wang L; Tan Y; Shang Y; Huo R; Fang C; Li C; Zhang L
Oncol Lett; 2023 Aug; 26(2):361. PubMed ID: 37545620
[TBL] [Abstract][Full Text] [Related]
12. A Systematic Review Informing the Management of Symptomatic Brain Radiation Necrosis After Stereotactic Radiosurgery and International Stereotactic Radiosurgery Society Recommendations.
Vellayappan B; Lim-Fat MJ; Kotecha R; De Salles A; Fariselli L; Levivier M; Ma L; Paddick I; Pollock BE; Regis J; Sheehan JP; Suh JH; Yomo S; Sahgal A
Int J Radiat Oncol Biol Phys; 2024 Jan; 118(1):14-28. PubMed ID: 37482137
[TBL] [Abstract][Full Text] [Related]
13. Bevacizumab as a treatment for radiation necrosis of brain metastases post stereotactic radiosurgery.
Boothe D; Young R; Yamada Y; Prager A; Chan T; Beal K
Neuro Oncol; 2013 Sep; 15(9):1257-63. PubMed ID: 23814264
[TBL] [Abstract][Full Text] [Related]
14. Bevacizumab as a treatment for radiation necrosis following stereotactic radiosurgery for brain metastases: clinical and radiation dosimetric impacts.
Li J; He J; Cai L; Lai M; Hu Q; Ren C; Wen L; Wang J; Zhou J; Zhou Z; Li S; Ye M; Shan C; Chen L; Zhou C
Ann Palliat Med; 2021 Feb; 10(2):2018-2026. PubMed ID: 33549015
[TBL] [Abstract][Full Text] [Related]
15. Interventions for the treatment of brain radionecrosis after radiotherapy or radiosurgery.
Chung C; Bryant A; Brown PD
Cochrane Database Syst Rev; 2018 Jul; 7(7):CD011492. PubMed ID: 29987845
[TBL] [Abstract][Full Text] [Related]
16. Single low-dose targeted bevacizumab infusion in adult patients with steroid-refractory radiation necrosis of the brain: a phase II open-label prospective clinical trial.
Dashti SR; Kadner RJ; Folley BS; Sheehan JP; Han DY; Kryscio RJ; Carter MB; Shields LBE; Plato BM; La Rocca RV; Spalding AC; Yao TL; Fraser JF
J Neurosurg; 2022 Dec; 137(6):1676-1686. PubMed ID: 35426830
[TBL] [Abstract][Full Text] [Related]
17. Targeted intraarterial anti-VEGF therapy for medically refractory radiation necrosis in the brain.
Dashti SR; Spalding A; Kadner RJ; Yao T; Kumar A; Sun DA; LaRocca R
J Neurosurg Pediatr; 2015 Jan; 15(1):20-5. PubMed ID: 25360851
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
